[Translation] A Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of oral XH-30002 capsules in patients with advanced solid tumors
观察XH-30002胶囊在晚期实体瘤患者中的安全性和耐受性,确定XH-30002胶囊单次及多次口服给药在晚期实体瘤患者中的最大耐受剂量(MTD)和/或II期推荐剂量(RP2D)。
[Translation] To observe the safety and tolerability of XH-30002 capsules in patients with advanced solid tumors, and to determine the maximum tolerated dose (MTD) and/or phase II recommended dose (RP2D) of XH-30002 capsules after single and multiple oral administration in patients with advanced solid tumors.